ISSN: 2165-7890
Department of Anesthesiology, Critical Care and Pain Medicine, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts, USA
Case Report
Can Botox Reduce Self-Injurious Behavior in Young Patients with Chronic Head Pain and Autism/Developmental Delay?
Author(s): Victoria Karian*, Cindy Yu-Hsing Chang, Zoe J. Schefter and Alyssa Lebel
Autism Spectrum Disorder (ASD) is characterized by neurological, psychiatric and medical comorbidities, revealed
in childhood, often including intellectual disability. Migraine is a very common neurological disorder, characterized
by moderate to severe head pain. It is likely that experiencing severe migraine head pain might lead a young person
with ASD to self-injurious behavior, such as striking or banging their heads. Botox for chronic migraine protocol
is used to treat patients with frequent migraine episodes. While this protocol is off-label for persons under 18
years, it has been used with good efficacy to treat teenagers with chronic migraine and head pain. Two patients in
our headache clinic population were identified as having ASD/intellectual disability, chronic migraine pain and
self-injurious behavior. These patients underwent the Botox for chronic mig.. View More»
DOI:
10.35248/2165-7890.22.12.333